Follow
Yu Shyr
Title
Cited by
Cited by
Year
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
BD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...
The Journal of clinical investigation 121 (7), 2750-2767, 2011
57122011
Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib
JA Sosman, KB Kim, L Schuchter, R Gonzalez, AC Pavlick, JS Weber, ...
New England Journal of Medicine 366 (8), 707-714, 2012
25522012
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
18052020
Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
JD Morrow, B Frei, AW Longmire, JM Gaziano, SM Lynch, Y Shyr, ...
New England Journal of Medicine 332 (18), 1198-1203, 1995
17761995
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
17712014
Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang, LM DeBusk, K Fukuda, B Fingleton, B Green-Jarvis, Y Shyr, ...
Cancer cell 6 (4), 409-421, 2004
13202004
Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection
BD Lehmann, B Jovanović, XI Chen, MV Estrada, KN Johnson, Y Shyr, ...
PloS one 11 (6), e0157368, 2016
12532016
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation
E Montgomery, MP Bronner, JR Goldblum, JK Greenson, MM Haber, ...
Human pathology 32 (4), 368-378, 2001
10182001
Proteomic patterns of tumour subsets in non-small-cell lung cancer
K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ...
The Lancet 362 (9382), 433-439, 2003
8112003
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention
H Mertz, V Morgan, G Tanner, D Pickens, R Price, Y Shyr, R Kessler
Gastroenterology 118 (5), 842-848, 2000
7782000
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor
AE Powell, Y Wang, Y Li, EJ Poulin, AL Means, MK Washington, ...
Cell 149 (1), 146-158, 2012
7482012
Nationwide trends in mastectomy for early-stage breast cancer
KL Kummerow, L Du, DF Penson, Y Shyr, MA Hooks
JAMA surgery 150 (1), 9-16, 2015
7132015
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer
JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ...
Gastroenterology 138 (3), 958-968, 2010
6772010
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
TW Miller, BT Hennessy, AM González-Angulo, EM Fox, GB Mills, H Chen, ...
The Journal of clinical investigation 120 (7), 2406-2413, 2010
5932010
Plasma cytokine levels predict mortality in patients with acute renal failure
EM Simmons, J Himmelfarb, MT Sezer, GM Chertow, RL Mehta, ...
Kidney international 65 (4), 1357-1365, 2004
5762004
DC isoketal-modified proteins activate T cells and promote hypertension
A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ...
The Journal of clinical investigation 124 (10), 4642-4656, 2014
5072014
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ...
Nature communications 7 (1), 10582, 2016
5032016
Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study
TA Ikizler, RL Wingard, J Harvell, Y Shyr, RM Hakim
Kidney international 55 (5), 1945-1951, 1999
4971999
Reamed intramedullary nailing of the femur: 551 cases
PR Wolinsky, E McCarty, Y Shyr, K Johnson
Journal of Trauma and Acute Care Surgery 46 (3), 392-399, 1999
4941999
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ
R Chinery, JA Brockman, MO Peeler, Y Shyr, RD Beauchamp, RJ Coffey
Nature medicine 3 (11), 1233-1241, 1997
4701997
The system can't perform the operation now. Try again later.
Articles 1–20